Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Oct 22, 2026)
Date Submitted: Aug 19, 2026
Open Peer Review Period: Aug 19, 2026 - Oct 14, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Cost-Benefit Analysis of a Digital Health Intervention for Postpartum Monitoring on Acute Care Costs
ABSTRACT
Background:
Digital health programs involve substantial implementation costs that are often not fully captured in economic evaluations. For managed care organizations considering coverage of these programs, understanding both implementation costs and cost-effectiveness is essential for informed decision-making.
Objective:
To evaluate the cost-benefit of Electronic Health Record (EHR)-integrated MOMitor™ postpartum monitoring smartphone application versus usual care by comparing 1-year postpartum acute care costs (hospitalizations and emergency department [ED] visits for common postpartum complications) and implementation costs (software, hardware, and labor).
Methods:
We conducted a retrospective cohort study using EHR data from a large quaternary care health system in the southeastern United States. English-speaking women aged ≥18 years, smartphone owners, with ≥1 prenatal visit within 8 weeks pre-delivery, who enrolled in MOMitor™ during delivery hospitalization were included as users. Non-users received usual care. Index date was defined as the day after discharge. Covariates were balanced using inverse probability of treatment weighting (IPTW), with absolute standardized mean differences (ASMDs) <0.1 indicating good balance. One-year postpartum acute care costs were estimated using a two-part model with a gamma distribution and log link. Models were adjusted for baseline acute care costs (8-week pre-delivery) and delivery hospitalization costs. Costs and benefits were monetized to estimate per-patient per-year (PPPY) costs from a healthcare system perspective, adjusted to 2023 USD with 3% annual inflation rate.
Results:
This analysis included 1,679 patients (mean [SD] age 27.0 [5.6] years; 27% Black), with 486 MOMitor™ users and 1,193 non-users. IPTW achieved good covariate balance (ASMDs <0.1) for all covariates. PPPY MOMitor™ implementation costs were $63 for MOMitor™ users only. IPTW-adjusted PPPY postpartum acute care costs were higher among MOMitor™ users ($2,003 vs. $1,151; p=0.61, yielding an incremental acute-care cost of $852 PPPY and a net program cost of $915 PPPY.
Conclusions:
MOMitor™ was not cost-saving during the first postpartum year. Higher acute care costs may partly reflect timely care escalation prompted by app-identified symptoms. Future studies incorporating outpatient costs, maternal morbidity, and quality-adjusted life years are needed. Evaluating MOMitor™ over a longer time horizon would help determine whether its upfront implementation costs are offset by downstream reductions in maternal morbidity and acute-care spending.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.